Drawing for FORMATRIS

USPTO serial 76625350

FORMATRIS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WELLS, CHRISTOPHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FORMATRIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SCOTT D WOLDOW

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of disorders and diseases of the respiratory system, gastrointestinal system, endocrine system, cardiovascular system, nervous system, musculoskeletal system, urinary system, integumentary system and reproductive system, pharmaceutical preparations for the treatment of blood diseases and disorders; dermatologic pharmaceutical preparations; antimycotic pharmaceutical preparations; hormone therapy preparations; medical diagnostic reagents; pharmaceutical preparations for the treatment of colds, coughs and influenza; pharmaceutical preparations for ophthalmic use; pharmaceutical preparations for treating dandruff; laxatives; analgesics, antipyretics, antispasmodics; oral contraceptives, antiseptics, pharmaceutical preparations for the treatment of hypotension, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of obesity; antiallergic pharmaceutical preparations; pharmaceutical preparations for the treatment of gout; anti-inflammatory pharmaceuticals; antibiotics, antineoplastics, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for asthma; pharmaceutical preparations for mouth and gum disease; pharmaceutical preparations for the treatment for vertigo, pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for treating AIDS and related symptoms; vitamin preparations; mineral additive dietary supplements; vaccines; X-ray contrast agentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 27, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 27, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 24, 2008EX5GSOU EXTENSION 5 GRANTED—
Dec 24, 2008EXT5SOU EXTENSION 5 FILED—
Dec 24, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 3, 2008EX4GSOU EXTENSION 4 GRANTED—
Jun 3, 2008EXT4SOU EXTENSION 4 FILED—
Jun 3, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 17, 2008EX3GSOU EXTENSION 3 GRANTED—
Dec 20, 2007EXT3SOU EXTENSION 3 FILED—
Dec 20, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 31, 2007EX2GSOU EXTENSION 2 GRANTED—
Jun 12, 2007EXT2SOU EXTENSION 2 FILED—
Jun 12, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 15, 2006EX1GSOU EXTENSION 1 GRANTED—
Dec 15, 2006EXT1SOU EXTENSION 1 FILED—
Dec 15, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 14, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 4, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2006NPUBNOTICE OF PUBLICATION—
Feb 16, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 3, 2006ALIEASSIGNED TO LIE—
Jan 30, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2005CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 28, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 27, 2005DOCKASSIGNED TO EXAMINER—
Jan 11, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance